IP Library Granted Patent US 10,130,578
Granted Patent B2
US 10,130,578 · App. 14/806,699 · Granted Nov 20, 2018

Topical delivery of skin compositions having low pH

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,130,578
App. No.
14/806,699
Granted
Nov 20, 2018
Kind
B2
Abstract

Low pH compositions for topical administration to skin are provided. They comprise a buffering agent having a pKa of about 2.8 to about 4.2 and a cosmetically acceptable active ingredient having a pKa within about 1 unit of the pKa of the buffering agent. The composition has a pH of about 3.3 to 4 and a buffer capacity of at least about 0.15. A method of increasing the topical delivery of a cosmetically acceptable active ingredient having a pKa of about 2.8 to about 4 is also provided.

Claims (32)

1. A topical composition comprising:

(a) about 3 to about 6 wt % of a buffering agent having a pKa of about 2.8 to about 4.2; and

(b) a cosmetically acceptable active ingredient comprising a glycosaminoglycan and having a pKa within about 1 unit of the pKa of the buffering agent;

wherein the composition has a pH of 3.3 to 4 and a buffer capacity of at least about 0.15.

2. The topical composition of claim 1 , wherein the cosmetically acceptable active ingredient has a pKa within about 0.7 unit of the pKa of the buffering agent.

3. The topical composition of claim 1 , wherein the cosmetically acceptable active ingredient comprises hyaluronic acid.

4. The topical composition of claim 1 , wherein the cosmetically acceptable active ingredient comprises cross-linked hyaluronic acid.

5. The topical composition of claim 1 , wherein the buffering agent is selected from the group consisting of lactic acid, glycolic acid, citric acid, tartaric acid, gluconic acid, and gluconolactone.

6. The topical composition of claim 1 , wherein the buffering agent is lactic acid.

7. A topical composition comprising:

(a) hyaluronic acid;

(b) about 3 to about 6 wt % of lactic acid;

(c) steareth 10;

(d) glycerol dilaurate; and

(e) glycerin;

wherein the composition has a pH of 3.3 to 4 and a buffer capacity of at least about 0.15.

8. The topical composition of claim 7 , wherein the hyaluronic acid comprises cross-linked hyaluronic acid.

9. The topical composition of claim 7 , further comprising a thickener selected from the group consisting of magnesium aluminum silicate, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, xanthan gum, silica, cetyl hydroxyethylcellulose, and polyacrylate-13/polyisobutylene/polysorbate-20 blend, and mixtures thereof.

10. The topical composition of claim 9 , wherein the thickener comprises hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer.

11. A method of increasing the topical delivery of a cosmetically acceptable active ingredient having a pKa of about 2.8 to about 4, comprising topically administering the cosmetically acceptable active ingredient in a composition having a pH of 3.3 to 4, a buffer capacity of at least about 0.15, and containing about 3 to about 6 wt % of a buffering agent having a pKa of about 2.8 to about 4.2.

12. The method of claim 11 , wherein said topical delivery is at least doubled compared with the topical delivery of the cosmetically acceptable active ingredient when contained in the composition having a pH of greater than 4.

13. The method of claim 11 , wherein said topical delivery is at least doubled compared with the topical delivery of the cosmetically acceptable active ingredient when contained in the composition not containing said buffering agent.

14. The method of claim 11 , wherein the cosmetically acceptable active ingredient comprises hyaluronic acid.

15. The method of claim 11 , wherein the cosmetically acceptable active ingredient comprises cross-linked hyaluronic acid.

16. A topical composition comprising:

(a) about 3 to about 6 wt % of lactic acid;

(b) steareth 10;

(c) glycerol dilaurate; and

(d) glycerin;

wherein the composition has a pH of 3.3 to 4 and a buffer capacity of at least about 0.15.

17. The topical composition of claim 16 , further comprising a thickener selected from the group consisting of magnesium aluminum silicate, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, xanthan gum, silica, cetyl hydroxyethylcellulose, and polyacrylate-13/polyisobutylene/polysorbate-20 blend, and mixtures thereof.

18. The topical composition of claim 17 , wherein the thickener comprises hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer.

Assignments (7)
CHANGE OF NAME Recorded Oct 28, 2024
From: JOHNSON & JOHNSON CONSUMER INC.
To: KENVUE BRANDS LLC
Reel/Frame 069267/0143 →
CERTIFICATE OF CONVERSION Recorded Jan 19, 2023
From: JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 062438/0521 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2023
From: JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 062438/0372 →
MERGER AND CHANGE OF NAME Recorded Jan 27, 2022
From: CHENANGO TWO LLC; CURRAHEE HOLDING COMPANY INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 058888/0210 →
MERGER Recorded Jan 27, 2022
From: CHENANGO ZERO LLC
To: CHENANGO TWO LLC
Reel/Frame 058888/0133 →
MERGER Recorded Jan 27, 2022
From: JOHNSON & JOHNSON CONSUMER INC.
To: CHENANGO ZERO LLC
Reel/Frame 059618/0521 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2015
From: BRILLOUET, ANNE-SOPHIE; DUFORT, MARISA DEVITA; FASSIH, ALI; GARCIA, DEVIN L.; HU, YA-PING; LI, WEN-HWA TING; PARSA, RAMINE; PATURI, JYOTSNA; ROSSETTI, DIANNE; SUN, YING; WANGARI-TALBOT, JANET; YATES, ROBERT WAYNE
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 036314/0671 →
Cited By (2)
US 12,582,584 US 12,678,390